Nexalin appoints Carolyn Shelton as SVP, clinical, quality, regulatory affairs
PremiumThe FlyNexalin appoints Carolyn Shelton as SVP, clinical, quality, regulatory affairs
27d ago
Nexalin Technology initiated with a Buy at Maxim
Premium
The Fly
Nexalin Technology initiated with a Buy at Maxim
1M ago
Nexalin Technology Welcomes New SVP Carolyn Shelton
Premium
Company Announcements
Nexalin Technology Welcomes New SVP Carolyn Shelton
2M ago
Nexalin Technology announces ‘positive’ study data in MDD
PremiumThe FlyNexalin Technology announces ‘positive’ study data in MDD
5M ago
3 Penny Stocks to Watch Now, 6/25/24
Premium
Market News
3 Penny Stocks to Watch Now, 6/25/24
5M ago
Nexalin Technology awarded patent related to deep-brain stimulation device
Premium
The Fly
Nexalin Technology awarded patent related to deep-brain stimulation device
5M ago
Nexalin Technology regains compliance with Nasdaq listing requirements
PremiumThe FlyNexalin Technology regains compliance with Nasdaq listing requirements
7M ago
Nexalin Technology files to sell $5.65M of common stock
Premium
The Fly
Nexalin Technology files to sell $5.65M of common stock
7M ago
Nexalin Technology issues letter to shareholders
Premium
The Fly
Nexalin Technology issues letter to shareholders
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100